DSCSA 2023 Extension: Requirements and Compliance Guidelines #fda

The Healthcare Distribution Alliance (HDA) has long been at the forefront of discussions surrounding pharmaceutical supply chain security. In recent times, the pharmaceutical industry has witnessed significant regulatory changes, including an enforcement delay for the Drug Supply Chain Security Act (DSCSA). This delay is labeled a “Stabilization” period by the FDA and is pivotal in addressing evolving challenges and further fortifying the integrity of the pharmaceutical supply chain. It is important to reiterate that the November 27, 2023 deadline for the full interoperable supply chain provisions of DSCSA is still in force—the FDA has just announced discretion in enforcing for one year. In this post, we will explore two important developments in the realm of DSCSA—the HDA conference and the FDA stabilization period—and their implications for the industry.

People also Ask:
* What is DSCSA?
* What are the DSCSA 2023 Requirements?
* What do I need to know about the FDA 2024 Extension for the DSCSA 2023/2024 Deadline

🗐 Links 🗐